Updated Data Matrix Available

Market Value | Market Volume | Epidemiology | Clinical Trials | Patent Landscape | Regulatory Approvals

Global Collagen Peptide Market $1.9 Billion by 2029

The global market for collagen peptide predicted to cross $1.9 billion by 2029, growing at a CAGR of 6.6% over the forecast period, driven by increasing prevalence of chronic diseases and wide range of collagen peptide applications in wound healing and regenerative medicine.

Global Collagen Peptide Market

Collagen protein is one of the key components of skin that maintains elasticity and hydration. The major sources of collagen include cattle, pigs and fish, while sources such as chicken, silkworm and other cell culture intermediates provide minimum yield for collagen peptide. 

  • Collagen peptide is manufactured through an enzymatic hydrolysis process and transformed by cosmeceutical and nutraceutical industries into collagen creams, injectables, capsules, powder supplements, drinks and others.
    • Cosmetic products that include collagen as an active ingredient are topical as well as injected intradermally as an anti-aging therapy.
      • Collagen is used in several medical devices and drugs is increasing owing to its characteristics such as biodegradability, high absorption rates, positive effect on wound healing, and easy availability.
      • Collagen sponges, shields, liposomes, microspheres, and nanoparticles also constitute some of the collagen-based drug delivery products used in various disorders.

The global market for collagen peptide report estimates the market size ($million 2019 to 2029), market volume (tons), market share, growth trends and forecast (CAGR%, 2023 to 2029).

The global market for collagen peptide segmented by source type (bovine, chicken, marine, porcine, and other farm animals), application (bone and joint health, cosmeceuticals, food and beverages, nutraceuticals, pet food, pharmaceuticals, and other industries), and geography.

  • Among the various source types for college peptide, the marine collagen anticipated to grow at a moderate rate over the forecast period, driven mainly due to high risk of disease transfer from other animal sources such as bovine and porcine.
    • Secondly, the risk of allergic reactions and high cost of marine collagen peptide products may restrain the growth of this segment.
  • Based on the applications, the cosmeceuticals segment accounted for the largest share of the global collagen peptide market, owing to the rising geriatric population, high social awareness about the aging symptoms and increasing demand for non-invasive cosmetic techniques.
    • Collagen peptide is widely used in the cosmetic, pharmaceutical, medical, and food industry because of its high biocompatibility, non-toxicity, and biodegradability.
      • Collagen has attracted significant attention of the cosmetic industry due to its interesting properties that include being a natural humectant and moisturizer for the skin.
        • Collagen peptides are used as a bioactive ingredient in nutricosmetic products and have been shown in preclinical studies to improve skin barrier function, to induce the synthesis of collagen and hyaluronic acid, and to promote fibroblast growth and migration. 

Geographically, the global collagen peptide market research report is divided into North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LA), and Rest of the World.

  • Geographically, the Asia Pacific and Latin America regions are identified as the most lucrative for future business opportunities.
    • Increasing affordability, easy availability of skilled labor, government support, improving healthcare infrastructure, favorable regulatory policies. and increasing awareness of collagen-based products are some of the factors driving the collagen peptide market growth in developing countries.

The global market for collagen peptide report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.

Major competitors operating in the global market collagen peptide and included in this report are Amicogen Inc., Biocell Technology LLC, Capsugel Inc., Catalent Pharma, Chinatech Peptides Co. Ltd, Gelita AG, InterHealth Nutraceuticals, Inc, Nitta Gelatin Inc., Norland Products, PB Gelatins, Sterling Gelatin, Rousselot International, Roxlor LLC and Weishardt International Group.

  • Source Type
    • Bovine
    • Chicken
    • Marine
    • Porcine
    • Other Farm Animals
  • Application
    • Bone and Joint Health
    • Cosmeceuticals
    • Food and Beverages
    • Nutraceuticals
    • Pet Food
    • Pharmaceuticals
    • Other Industries
  • Geography
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC
    • Latin America (Brazil, Mexico, Rest of LA)
    • Rest of the World
  • Company Profiles
    • Amicogen, Inc.
    • BioCell Technology LLC
    • Capsugel Belgium NV
    • Catalent, Inc.
    • ChinaTech Peptide Co. Ltd.
    • GELITA AG
    • InterHealth Nutraceuticals, Inc.
    • Nitta Gelatin, Inc.
    • Norland Products, Inc.
    • Pont Brule (PB) Gelatins GmbH
    • Rousselot International
    • Roxlor LLC
    • Sterling Gelatin
    • Weishardt International Group

To request Table of Contents and Sample Pages of this report visit:
https://www.ihealthcareanalyst.com/report/collagen-peptide-market/

Related publications:

    Request ToC/Sample information for this market analysis

    Full Name*

    Company Email*

    Phone Number* [Please add country code]

    Subject*

    Message*

    Secure Online Payment

    iHealthcareAnalyst, Inc.

    Contact Address

    US Office: 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043, United States
    Phone: +1 (314) 315-4764
    India Office: 5, Shilpa Chambers, Opp. J. M. Road, Shivajinager, Pune 411005, India
    Phone: +91 (20) 25898524
    Email: sales@ihealthcareanalyst.com